1-Propionyl-LSD, often abbreviated as copyright, represents a relatively curious area of copyright investigation. Developed as a prodrug of LSD, it’s thought to offer a possibly altered subjective experience compared to the original compound. While limited data currently exists regarding its specific effects and pharmacokinetics , initial observa